Sign in

CIK 0000907654

  • Non-accelerated filer
  • Smaller reporting company

Oruka Therapeutics, Inc.

Sign in to watch
Ticker
ORKA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363855489
Phone
+1 650-606-7910
Business address
855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
Former names
ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market sale CFO and COO sold 21,000 shares at an average $3.61 ($75,851)
  3. 4 Open-market sale Director sold 50,600 shares at an average $3.86 ($195,287)
  4. 4 Open-market sale Former 10% owner sold 50,600 shares at an average $3.86 ($195,287)
  5. 4 Open-market sale Former 10% owner sold 149,208 shares at an average $4.08 ($608,228)
  6. 4 Open-market sale Director sold 149,208 shares at an average $4.08 ($608,228)
  7. 4 Other disposition 10% owner disposed of 342,375 shares (other)
  8. 4 Other disposition Director disposed of 342,375 shares (other)
  9. 4 Other disposition 10% owner disposed of 53,000 shares (other)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 5 Insider Annual Insider Trading Report

Page 16 of 23 · 459 filings